← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1999Last known activity
Oct 1, 2024
Timeline
1940s
- Jan 1, 1949
Dutch Cancer Society— Founded
Drugs by trial phase (64 distinct, 37 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (30 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (12 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenoma
- Adenomatous Polyposis Coli
- Breast Neoplasms
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Ductal, Breast
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Duodenal Neoplasms
- Fever
- Gastrointestinal Neoplasms
- Laryngeal Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Melanoma
- Mucositis
- Multiple Myeloma
- Nasopharyngeal Neoplasms
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplastic Cells, Circulating
- Neutropenia
- Ovarian Neoplasms
- Peritoneal Neoplasms
- Precancerous Conditions
- Primary Myelofibrosis
- Rectal Neoplasms
- Salivary Gland Neoplasms
- Uterine Cervical Neoplasms
Recent trials (37)
- NCT06484491CollaboratorN/AOct 1, 2024
- NCT06095674CollaboratorPhase 1Jan 31, 2024
- NCT06052696CollaboratorPhase 4Dec 1, 2023
- NCT06095362CollaboratorPhase 1Nov 29, 2021
- NCT05255653CollaboratorPhase 2/Phase 3Nov 11, 2021
- NCT04927780CollaboratorPhase 3Sep 7, 2021
- NCT06015854CollaboratorPhase 2Mar 23, 2021
- NCT05076942CollaboratorPhase 2Jan 1, 2021
- NCT04648189CollaboratorPhase 2Jan 1, 2021
- NCT04729543CollaboratorPhase 1/Phase 2Oct 20, 2020
- NCT04347616CollaboratorPhase 1/Phase 2Oct 1, 2020
- NCT04291300CollaboratorPhase 2May 1, 2020
- NCT04125277CollaboratorN/ANov 30, 2019
- NCT04099901CollaboratorPhase 2Oct 31, 2019
- NCT03749850CollaboratorPhase 1Sep 30, 2019
Details
- Founded
- Amsterdam, NL Jan 1, 1949
- Last known activity
- Oct 1, 2024